Literature DB >> 11896615

Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.

Keltouma Driouch1, Hans Prydz, Rossana Monese, Henning Johansen, Rosette Lidereau, Eirik Frengen.   

Abstract

The presence of putative tumor-suppressor genes on chromosome 16q23.2-24.1 has been suggested by LOH analysis in several cancer types. This region overlaps with the fragile site FRA16D and the region of homozygous deletions found in several cancer types. The candidate gene WWOX/FOR has been mapped within this region. The mouse homologue of the WWOX protein has been defined as an apoptogenic protein and an essential partner of p53 in cell death, supporting WWOX as a tumor suppressor gene candidate. We performed an expression study of the WWOX/FOR gene in a series of human breast tumors and breast cancer cell lines, and detected reduced expression of the WWOX/FOR transcript in a series of breast cancer cells. Furthermore, identification of two distinct alternative WWOX transcripts expressed at high levels in human tumors suggests an involvement of the WWOX gene in breast cancer progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896615     DOI: 10.1038/sj.onc.1205273

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  Matrix attachment region (MAR) properties and abnormal expansion of AT island minisatellites in FRA16B fragile sites in leukemic CEM cells.

Authors:  Jennifer A Jackson; Alex V Trevino; Maryanne C Herzig; Terence S Herman; Jan M Woynarowski
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

Review 2.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

3.  Genetic alterations of the WWOX gene in breast cancer.

Authors:  Seda Ekizoglu; Mahmut Muslumanoglu; Nejat Dalay; Nur Buyru
Journal:  Med Oncol       Date:  2011-10-08       Impact factor: 3.064

4.  WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721.

Authors:  Ben-Shun Hu; Jing-Wang Tan; Guo-Hua Zhu; Dan-Feng Wang; Xian Zhou; Zhi-Qiang Sun
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

5.  Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Hiroshi Handa; Yoshiko Sasaki; Hikaru Hattori; Lobna Alkebsi; Tetsuhiro Kasamatsu; Takayuki Saitoh; Takeki Mitsui; Akihiko Yokohama; Norifumi Tsukamoto; Morio Matsumoto; Hirokazu Murakami
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

Review 6.  Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.

Authors:  Yao Chang; Yu-Yan Lan; Jenn-Ren Hsiao; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-07

Review 7.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14

8.  Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.

Authors:  Rami I Aqeilan; Yuri Pekarsky; Juan J Herrero; Alexey Palamarchuk; Jean Letofsky; Teresa Druck; Francesco Trapasso; Shuang-Yin Han; Gerry Melino; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

9.  Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme.

Authors:  Katarzyna Kosla; Elzbieta Pluciennik; Agata Kurzyk; Dorota Jesionek-Kupnicka; Radzislaw Kordek; Piotr Potemski; Andrzej K Bednarek
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

10.  Loss of WWOX expression in human extrahepatic cholangiocarcinoma.

Authors:  Mei Wang; Jun Gu; Yajie Wang; Biao Gong
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-16       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.